| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchopulmonary Dysplasia | 19 | 2025 | 217 | 8.190 |
Why?
|
| Hyperoxia | 19 | 2025 | 135 | 6.260 |
Why?
|
| Lung | 24 | 2025 | 1533 | 4.540 |
Why?
|
| Receptors, Aryl Hydrocarbon | 10 | 2022 | 65 | 4.370 |
Why?
|
| Hypertension, Pulmonary | 11 | 2025 | 453 | 4.070 |
Why?
|
| Adrenomedullin | 6 | 2025 | 82 | 3.770 |
Why?
|
| Lipopolysaccharides | 6 | 2024 | 304 | 2.210 |
Why?
|
| Omeprazole | 5 | 2016 | 101 | 2.030 |
Why?
|
| Endothelial Cells | 7 | 2020 | 521 | 1.850 |
Why?
|
| Animals, Newborn | 14 | 2025 | 1015 | 1.380 |
Why?
|
| Pulmonary Alveoli | 6 | 2024 | 140 | 1.380 |
Why?
|
| Disease Models, Animal | 11 | 2025 | 4666 | 1.180 |
Why?
|
| Cytochrome P-450 CYP1A1 | 5 | 2017 | 82 | 1.160 |
Why?
|
| Acute Lung Injury | 3 | 2022 | 68 | 1.100 |
Why?
|
| Signal Transduction | 7 | 2024 | 4670 | 1.000 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 2 | 2017 | 25 | 0.970 |
Why?
|
| Isoxazoles | 2 | 2017 | 32 | 0.970 |
Why?
|
| Infant, Premature | 7 | 2024 | 858 | 0.950 |
Why?
|
| Mice, Inbred C57BL | 15 | 2024 | 4713 | 0.940 |
Why?
|
| Pulmonary Circulation | 2 | 2017 | 112 | 0.940 |
Why?
|
| Cell Proliferation | 5 | 2024 | 2463 | 0.910 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2016 | 137 | 0.880 |
Why?
|
| Oxidative Stress | 7 | 2018 | 795 | 0.820 |
Why?
|
| Interleukin-17 | 1 | 2024 | 125 | 0.810 |
Why?
|
| Pneumonia | 4 | 2024 | 340 | 0.790 |
Why?
|
| Vascular Remodeling | 2 | 2020 | 46 | 0.760 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2020 | 106 | 0.750 |
Why?
|
| Proton Pump Inhibitors | 2 | 2015 | 276 | 0.740 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 643 | 0.740 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 2 | 2024 | 401 | 0.730 |
Why?
|
| Fetus | 4 | 2018 | 566 | 0.700 |
Why?
|
| Animals | 25 | 2026 | 33839 | 0.700 |
Why?
|
| Mice | 18 | 2026 | 18215 | 0.690 |
Why?
|
| Transcriptome | 4 | 2024 | 1113 | 0.640 |
Why?
|
| Receptor, TIE-2 | 1 | 2020 | 13 | 0.640 |
Why?
|
| MAP Kinase Signaling System | 2 | 2020 | 302 | 0.630 |
Why?
|
| Hydrogen Peroxide | 2 | 2018 | 116 | 0.610 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2020 | 185 | 0.590 |
Why?
|
| Integrases | 1 | 2020 | 157 | 0.590 |
Why?
|
| Infant, Newborn | 15 | 2024 | 8523 | 0.570 |
Why?
|
| Catalase | 1 | 2018 | 63 | 0.560 |
Why?
|
| Cytochrome P-450 CYP1A2 | 2 | 2015 | 48 | 0.560 |
Why?
|
| Superoxide Dismutase | 1 | 2018 | 176 | 0.520 |
Why?
|
| Receptors, Adrenomedullin | 1 | 2017 | 16 | 0.520 |
Why?
|
| Lung Injury | 5 | 2020 | 122 | 0.510 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2017 | 78 | 0.510 |
Why?
|
| Neovascularization, Physiologic | 1 | 2018 | 196 | 0.500 |
Why?
|
| Heme Oxygenase-1 | 1 | 2016 | 33 | 0.500 |
Why?
|
| Echocardiography, Doppler, Pulsed | 1 | 2016 | 16 | 0.490 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2018 | 239 | 0.490 |
Why?
|
| Proteome | 1 | 2018 | 286 | 0.480 |
Why?
|
| Microvessels | 1 | 2016 | 58 | 0.480 |
Why?
|
| Immunologic Factors | 1 | 2017 | 189 | 0.460 |
Why?
|
| Transcription Factor RelB | 1 | 2015 | 4 | 0.450 |
Why?
|
| Fetal Growth Retardation | 1 | 2017 | 253 | 0.450 |
Why?
|
| Capillaries | 1 | 2015 | 64 | 0.440 |
Why?
|
| Respiratory Mucosa | 1 | 2015 | 93 | 0.440 |
Why?
|
| Cells, Cultured | 5 | 2018 | 2895 | 0.430 |
Why?
|
| Up-Regulation | 1 | 2017 | 828 | 0.420 |
Why?
|
| Respiration, Artificial | 1 | 2017 | 505 | 0.420 |
Why?
|
| Vasopressins | 1 | 2013 | 42 | 0.390 |
Why?
|
| Heart | 1 | 2017 | 659 | 0.390 |
Why?
|
| Cell Survival | 4 | 2018 | 831 | 0.380 |
Why?
|
| Pulmonary Artery | 1 | 2016 | 436 | 0.380 |
Why?
|
| Humans | 30 | 2026 | 130350 | 0.370 |
Why?
|
| Antioxidants | 1 | 2015 | 335 | 0.370 |
Why?
|
| Smoking | 1 | 2017 | 928 | 0.370 |
Why?
|
| Biomarkers | 3 | 2020 | 3381 | 0.360 |
Why?
|
| Vasoconstrictor Agents | 1 | 2013 | 137 | 0.360 |
Why?
|
| Hypotension | 1 | 2013 | 182 | 0.340 |
Why?
|
| Liver | 3 | 2015 | 1788 | 0.340 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2011 | 105 | 0.330 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2018 | 1610 | 0.310 |
Why?
|
| Oxygen | 1 | 2013 | 550 | 0.300 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 1807 | 0.290 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2020 | 88 | 0.290 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2011 | 298 | 0.290 |
Why?
|
| Apoptosis | 3 | 2024 | 1829 | 0.290 |
Why?
|
| Time Factors | 4 | 2024 | 6196 | 0.290 |
Why?
|
| Actins | 2 | 2024 | 315 | 0.280 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 559 | 0.280 |
Why?
|
| Gene Expression Regulation | 4 | 2022 | 2334 | 0.280 |
Why?
|
| Mice, Transgenic | 2 | 2025 | 2333 | 0.280 |
Why?
|
| Mice, Knockout | 6 | 2026 | 3829 | 0.270 |
Why?
|
| Inflammation | 4 | 2022 | 1483 | 0.270 |
Why?
|
| Epithelial Cells | 1 | 2011 | 907 | 0.250 |
Why?
|
| Gestational Age | 2 | 2023 | 1206 | 0.250 |
Why?
|
| Ductus Arteriosus, Patent | 2 | 2018 | 146 | 0.230 |
Why?
|
| Organ Size | 3 | 2017 | 410 | 0.230 |
Why?
|
| Feasibility Studies | 3 | 2017 | 813 | 0.230 |
Why?
|
| Microbiota | 2 | 2022 | 437 | 0.220 |
Why?
|
| Endothelium, Vascular | 2 | 2018 | 467 | 0.210 |
Why?
|
| Phenyl Ethers | 1 | 2024 | 12 | 0.210 |
Why?
|
| Infant, Premature, Diseases | 2 | 2024 | 252 | 0.210 |
Why?
|
| Apnea | 1 | 2024 | 26 | 0.210 |
Why?
|
| Female | 13 | 2021 | 70308 | 0.200 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2024 | 95 | 0.200 |
Why?
|
| Pregnancy | 6 | 2021 | 7386 | 0.200 |
Why?
|
| Random Allocation | 2 | 2015 | 414 | 0.200 |
Why?
|
| RNA, Small Interfering | 2 | 2015 | 665 | 0.190 |
Why?
|
| Vascular Resistance | 1 | 2023 | 182 | 0.190 |
Why?
|
| Mice, Inbred DBA | 2 | 2013 | 43 | 0.180 |
Why?
|
| Nervous System Diseases | 1 | 2026 | 395 | 0.180 |
Why?
|
| Gene Dosage | 2 | 2021 | 436 | 0.180 |
Why?
|
| Killer Cells, Natural | 1 | 2024 | 352 | 0.180 |
Why?
|
| Mice, 129 Strain | 1 | 2021 | 96 | 0.170 |
Why?
|
| Dysbiosis | 2 | 2022 | 143 | 0.170 |
Why?
|
| Sequence Analysis, RNA | 1 | 2024 | 411 | 0.170 |
Why?
|
| Chemokine CCL2 | 2 | 2011 | 112 | 0.170 |
Why?
|
| Ligands | 1 | 2022 | 482 | 0.160 |
Why?
|
| Reactive Oxygen Species | 2 | 2015 | 526 | 0.160 |
Why?
|
| Receptor Activity-Modifying Protein 2 | 1 | 2020 | 12 | 0.160 |
Why?
|
| Malondialdehyde | 2 | 2016 | 49 | 0.150 |
Why?
|
| Molecular Targeted Therapy | 1 | 2022 | 384 | 0.150 |
Why?
|
| Male | 9 | 2020 | 64440 | 0.140 |
Why?
|
| Neutrophil Infiltration | 3 | 2015 | 63 | 0.140 |
Why?
|
| Alprostadil | 1 | 2018 | 20 | 0.140 |
Why?
|
| Atmosphere Exposure Chambers | 1 | 2017 | 1 | 0.140 |
Why?
|
| Respiratory System | 1 | 2018 | 96 | 0.140 |
Why?
|
| Ultrasonography, Doppler, Pulsed | 1 | 2017 | 20 | 0.140 |
Why?
|
| Chorioamnionitis | 1 | 2017 | 37 | 0.130 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2017 | 41 | 0.130 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2020 | 324 | 0.130 |
Why?
|
| Neonatal Sepsis | 1 | 2017 | 40 | 0.130 |
Why?
|
| Pregnancy Complications | 2 | 2017 | 539 | 0.130 |
Why?
|
| Perinatal Care | 1 | 2017 | 65 | 0.130 |
Why?
|
| Structure-Activity Relationship | 1 | 2018 | 553 | 0.130 |
Why?
|
| Vasodilator Agents | 1 | 2018 | 198 | 0.120 |
Why?
|
| Infant, Extremely Premature | 1 | 2017 | 112 | 0.120 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2017 | 81 | 0.120 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2016 | 90 | 0.120 |
Why?
|
| Peptide Fragments | 1 | 2020 | 687 | 0.120 |
Why?
|
| Databases, Genetic | 2 | 2016 | 500 | 0.120 |
Why?
|
| Cytochrome P-450 Enzyme Inducers | 1 | 2015 | 2 | 0.120 |
Why?
|
| Cell Cycle | 1 | 2018 | 597 | 0.120 |
Why?
|
| Injections, Intraperitoneal | 1 | 2015 | 65 | 0.120 |
Why?
|
| Primary Cell Culture | 1 | 2015 | 105 | 0.110 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2017 | 226 | 0.110 |
Why?
|
| Stroke Volume | 1 | 2017 | 534 | 0.110 |
Why?
|
| Anti-Ulcer Agents | 1 | 2015 | 110 | 0.110 |
Why?
|
| Infant Care | 1 | 2005 | 45 | 0.110 |
Why?
|
| von Willebrand Factor | 1 | 2016 | 191 | 0.110 |
Why?
|
| Cell Death | 1 | 2015 | 231 | 0.110 |
Why?
|
| Necrosis | 1 | 2015 | 194 | 0.110 |
Why?
|
| RNA Interference | 1 | 2016 | 492 | 0.110 |
Why?
|
| Benzo(a)pyrene | 1 | 2014 | 24 | 0.100 |
Why?
|
| Transfection | 1 | 2016 | 959 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 382 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2017 | 767 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 525 | 0.100 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 380 | 0.100 |
Why?
|
| Lypressin | 1 | 2013 | 17 | 0.100 |
Why?
|
| Blotting, Western | 2 | 2014 | 1016 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 995 | 0.100 |
Why?
|
| Interleukin-6 | 1 | 2015 | 410 | 0.100 |
Why?
|
| Myocardium | 1 | 2017 | 857 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 479 | 0.090 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 137 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 636 | 0.090 |
Why?
|
| Hemodynamics | 1 | 2016 | 805 | 0.090 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2013 | 86 | 0.090 |
Why?
|
| Echocardiography | 1 | 2017 | 1127 | 0.090 |
Why?
|
| Cytoprotection | 1 | 2011 | 37 | 0.090 |
Why?
|
| Microsomes | 1 | 2011 | 35 | 0.090 |
Why?
|
| Enzyme Induction | 1 | 2011 | 92 | 0.090 |
Why?
|
| Mice, Inbred Strains | 1 | 2011 | 263 | 0.080 |
Why?
|
| Pulmonary Edema | 1 | 2011 | 54 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 966 | 0.080 |
Why?
|
| Computational Biology | 1 | 2016 | 862 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 373 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 2290 | 0.080 |
Why?
|
| Disease Progression | 1 | 2016 | 2193 | 0.080 |
Why?
|
| Incidence | 1 | 2017 | 3313 | 0.080 |
Why?
|
| RNA, Messenger | 1 | 2015 | 2551 | 0.080 |
Why?
|
| Infant | 2 | 2023 | 13240 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 1206 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 1594 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 3403 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 3747 | 0.060 |
Why?
|
| Ataxin-1 | 1 | 2026 | 166 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2026 | 423 | 0.060 |
Why?
|
| Lipid Peroxidation | 2 | 2015 | 92 | 0.050 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2024 | 23 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 3712 | 0.050 |
Why?
|
| Osteomalacia | 1 | 2003 | 7 | 0.050 |
Why?
|
| Rickets | 1 | 2003 | 9 | 0.050 |
Why?
|
| Risk Factors | 1 | 2017 | 10944 | 0.050 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2024 | 254 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2026 | 763 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2024 | 452 | 0.040 |
Why?
|
| Mutation | 1 | 2013 | 6094 | 0.040 |
Why?
|
| Metabolome | 1 | 2022 | 324 | 0.040 |
Why?
|
| Reference Standards | 1 | 2020 | 232 | 0.040 |
Why?
|
| ROC Curve | 1 | 2020 | 610 | 0.030 |
Why?
|
| Dinoprost | 1 | 2015 | 24 | 0.030 |
Why?
|
| F2-Isoprostanes | 1 | 2015 | 19 | 0.030 |
Why?
|
| Aldehydes | 1 | 2015 | 27 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 2087 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2015 | 247 | 0.030 |
Why?
|
| India | 1 | 2005 | 233 | 0.030 |
Why?
|
| Brain | 1 | 2026 | 3173 | 0.030 |
Why?
|
| Cytochrome P-450 CYP1B1 | 1 | 2014 | 30 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 2014 | 99 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 2005 | 169 | 0.030 |
Why?
|
| Adult | 1 | 2015 | 31094 | 0.030 |
Why?
|
| DNA Adducts | 1 | 2014 | 70 | 0.030 |
Why?
|
| Gene Order | 1 | 2013 | 81 | 0.020 |
Why?
|
| Breast Feeding | 1 | 2005 | 234 | 0.020 |
Why?
|
| Neutrophils | 1 | 2015 | 361 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2013 | 198 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2013 | 583 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2013 | 1046 | 0.020 |
Why?
|
| Body Weight | 1 | 2014 | 983 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2005 | 503 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 2397 | 0.020 |
Why?
|
| Length of Stay | 1 | 2005 | 1398 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 3469 | 0.020 |
Why?
|
| Rats | 1 | 2014 | 3371 | 0.020 |
Why?
|